欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0229/001
药品名称Symbicort Turbuhaler
活性成分
    • budesonide 160.0 µg
    • formoterol dihydrate 4.5 µg
剂型Inhalation powder
上市许可持有人AstraZeneca AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Croatia (HR)
    • Poland (PL)
    • Latvia (LV)
      Symbicort Turbuhaler 160 mikrogrami/4,5 mikrogrami/inhalācijā, inhalācijas pulveris
    • Lithuania (LT)
      Symbicort Turbuhaler 160/4,5 mikrogramo/dozėje inhaliaciniai milteliai
    • Estonia (EE)
    • Hungary (HU)
      SYMBICORT TURBUHALER 4,5 mikrogramm/160 mikrogramm inhalációs por
    • Bulgaria (BG)
    • Cyprus (CY)
      SYMBICORT 160/4.5MCG/INHALATION
    • Czechia (CZ)
      Symbicort Turbuhaler 200/6 μg/inhalation (metered dose)
    • Romania (RO)
      Symbicort Turbuhaler 160 micrograme/ 4,5 micrograme pulbere de inhalat
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Germany (DE)
      Symbicort Turbohaler 320/9
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Ireland (IE)
      Symbicort® Turbohaler
    • Austria (AT)
      Symbicort Turbohaler 160 Mikrogramm/4,5 Mikrogramm pro Dosis Pulver zur Inhalation
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
      Symbicort Turbohaler
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
许可日期2000/12/22
最近更新日期2024/04/19
药物ATC编码
    • R03AK07 formoterol and budesonide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed Combination Article 4.8b
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase